Ferguson Wellman Capital Management Inc. Boosts Holdings in Stryker Corporation $SYK

Ferguson Wellman Capital Management Inc. raised its holdings in shares of Stryker Corporation (NYSE:SYK) by 2.5% in the fourth quarter, Holdings Channel reports. The institutional investor owned 184,554 shares of the medical technology company’s stock after acquiring an additional 4,515 shares during the period. Stryker comprises about 1.0% of Ferguson Wellman Capital Management Inc.’s portfolio, making the stock its 28th biggest holding. Ferguson Wellman Capital Management Inc.’s holdings in Stryker were worth $64,865,000 at the end of the most recent quarter.

Other institutional investors have also added to or reduced their stakes in the company. Armstrong Advisory Group Inc. boosted its stake in shares of Stryker by 12.3% during the 3rd quarter. Armstrong Advisory Group Inc. now owns 247 shares of the medical technology company’s stock worth $91,000 after acquiring an additional 27 shares during the last quarter. Venturi Wealth Management LLC increased its stake in shares of Stryker by 1.4% in the 3rd quarter. Venturi Wealth Management LLC now owns 1,904 shares of the medical technology company’s stock worth $704,000 after purchasing an additional 27 shares in the last quarter. Patriot Financial Group Insurance Agency LLC raised its holdings in Stryker by 3.9% in the 3rd quarter. Patriot Financial Group Insurance Agency LLC now owns 745 shares of the medical technology company’s stock worth $275,000 after purchasing an additional 28 shares during the period. Wolff Wiese Magana LLC lifted its position in Stryker by 2.3% during the third quarter. Wolff Wiese Magana LLC now owns 1,271 shares of the medical technology company’s stock valued at $470,000 after purchasing an additional 28 shares in the last quarter. Finally, Lantz Financial LLC lifted its position in Stryker by 5.0% during the third quarter. Lantz Financial LLC now owns 608 shares of the medical technology company’s stock valued at $225,000 after purchasing an additional 29 shares in the last quarter. 77.09% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

SYK has been the subject of a number of analyst reports. Raymond James Financial upgraded Stryker from a “market perform” rating to an “outperform” rating and set a $418.00 price target for the company in a research report on Tuesday, January 6th. Jefferies Financial Group reaffirmed a “buy” rating and set a $465.00 price objective on shares of Stryker in a research report on Wednesday, March 4th. Evercore set a $390.00 target price on shares of Stryker in a report on Monday, January 5th. TD Cowen cut shares of Stryker from a “buy” rating to a “hold” rating and set a $387.00 target price on the stock. in a research note on Monday, January 26th. Finally, Citigroup reaffirmed a “market outperform” rating on shares of Stryker in a report on Friday, January 30th. Fourteen research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $427.50.

Insider Activity at Stryker

In related news, Director Ronda E. Stryker sold 250,000 shares of the company’s stock in a transaction on Wednesday, February 4th. The shares were sold at an average price of $362.92, for a total transaction of $90,730,000.00. Following the completion of the transaction, the director owned 2,457,331 shares in the company, valued at approximately $891,814,566.52. This represents a 9.23% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Company insiders own 5.90% of the company’s stock.

Stryker Stock Performance

NYSE SYK opened at $327.34 on Thursday. The company has a quick ratio of 1.21, a current ratio of 1.89 and a debt-to-equity ratio of 0.66. Stryker Corporation has a twelve month low of $324.93 and a twelve month high of $404.87. The business has a 50-day moving average price of $361.50 and a 200-day moving average price of $364.58. The firm has a market cap of $125.37 billion, a price-to-earnings ratio of 38.97, a price-to-earnings-growth ratio of 1.92 and a beta of 0.85.

Stryker (NYSE:SYK) last posted its quarterly earnings results on Thursday, January 29th. The medical technology company reported $4.47 EPS for the quarter, topping analysts’ consensus estimates of $4.40 by $0.07. Stryker had a return on equity of 24.41% and a net margin of 12.92%.The company had revenue of $7.17 billion for the quarter, compared to analysts’ expectations of $7.12 billion. During the same period in the previous year, the firm earned $4.01 EPS. The firm’s revenue was up 11.4% compared to the same quarter last year. As a group, equities research analysts predict that Stryker Corporation will post 13.47 EPS for the current fiscal year.

Stryker Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Thursday, April 30th. Stockholders of record on Tuesday, March 31st will be issued a $0.88 dividend. This represents a $3.52 annualized dividend and a dividend yield of 1.1%. The ex-dividend date of this dividend is Tuesday, March 31st. Stryker’s payout ratio is 41.90%.

Stryker Profile

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.